Literature DB >> 6151954

Beta blockers and fatigue.

P E Hall, M J Kendall, S R Smith.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6151954     DOI: 10.1111/j.1365-2710.1984.tb01089.x

Source DB:  PubMed          Journal:  J Clin Hosp Pharm        ISSN: 0143-3180


× No keyword cloud information.
  6 in total

1.  Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.

Authors:  R V Lewis; L E Ramsay; P R Jackson; W W Yeo; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers.

Authors:  H M Lewis; M J Kendall; S R Smith; J R Bratty
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 3.  Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.

Authors:  M J Kendall; S R Maxwell; A Sandberg; G Westergren
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

4.  Exploring adaptations to the modified shuttle walking test.

Authors:  Kate Woolf-May; Steve Meadows
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

Review 5.  Neuropsychiatric Consequences of Lipophilic Beta-Blockers.

Authors:  Sabina Alexandra Cojocariu; Alexandra Maștaleru; Radu Andy Sascău; Cristian Stătescu; Florin Mitu; Maria Magdalena Leon-Constantin
Journal:  Medicina (Kaunas)       Date:  2021-02-09       Impact factor: 2.430

6.  Appropriateness of the metabolic equivalent (MET) as an estimate of exercise intensity for post-myocardial infarction patients.

Authors:  Kate Woolf-May; Steve Meadows
Journal:  BMJ Open Sport Exerc Med       Date:  2017-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.